A detailed history of Prairie View Partners, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Prairie View Partners, LLC holds 816 shares of LLY stock, worth $738,790. This represents 0.07% of its overall portfolio holdings.

Number of Shares
816
Previous 804 1.49%
Holding current value
$738,790
Previous $469,000 35.39%
% of portfolio
0.07%
Previous 0.06%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 03, 2024

BUY
$592.2 - $792.28 $7,106 - $9,507
12 Added 1.49%
816 $635,000
Q2 2023

Aug 04, 2023

BUY
$350.74 - $468.98 $1,402 - $1,875
4 Added 0.5%
804 $377,000
Q4 2022

Jan 30, 2023

BUY
$321.55 - $374.67 $64,310 - $74,934
200 Added 33.33%
800 $292,000
Q2 2022

Jul 22, 2022

BUY
$278.73 - $327.27 $27,873 - $32,727
100 Added 20.0%
600 $195,000
Q3 2021

Oct 12, 2021

BUY
$221.6 - $272.71 $110,800 - $136,355
500 New
500 $116,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $860B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Prairie View Partners, LLC Portfolio

Follow Prairie View Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prairie View Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prairie View Partners, LLC with notifications on news.